Staged Stem Cell-enriched Tissue (SET) Injections for Soft Tissue Augmentation in Hostile Recipient Areas: A Preliminary Report



Autologous fat transplantation is frequently used for a variety of cosmetic treatments and difficult reconstructive indications such as involutional disorders, hemifacial atrophy, sequelae of radiation therapy, or similar problems. However, the limitations of fat transplantation are well known in such difficult cases, particularly the long-term unpredictability of volume maintenance. The ideal method of preparing autologous fat grafts optimizes tissue survival and reduces the variability of outcomes. We propose that enriching traditionally prepared fat grafts with adipose-derived regenerative cells (ADRCs) represents one such method.


Using a staged approach, we performed cell-enriched fat transfer by injecting autologous ADRCs into soft tissue that was recently grafted using traditional methods of fat transfer. Over a 3-year period, data were prospectively collected from 29 patients who underwent a single session of stem cell-enriched tissue injections (SET).


Cell-enriched grafts ranged in volume from 10 to 390 cc per recipient area and were obtained by manual or automated processes. The mean follow-up period was 10 months. Postoperative atrophy of the injected tissue was minimal and subjectively did not change after 8 weeks. Of note, historically reported rates of atrophy range from 20 to 80%. All patients were satisfied with the primary result with no need for a secondary session except for the cosmetic cases.


These preliminary results suggest that SET is safe and may provide superior results compared to traditional fat grafting. By performing the procedure in a staged approach, operating room expenses are minimized, which ultimately decreases the cost of the procedure. Adipose-derived regenerative cells may mitigate early ischemia by increasing angiogenesis, decreasing apoptosis, and modulating the local inflammatory response. This technique may be of particular value to the surgeon when grafting high volumes of fat or when faced with hostile recipient area conditions, including fibrosis and post radiation.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4


  1. 1.

    Domergue S, Psomas C, Yachouh J et al (2006) Fat microinfiltration autografting for facial restructuring in HIV patients. J Craniomaxillofac Surg 34:484–488

    PubMed  Article  Google Scholar 

  2. 2.

    Shakhov AA (2002) Fat transplantation and breast augmentation. Aesthetic Plast Surg 26:323–325

    PubMed  Article  Google Scholar 

  3. 3.

    Tzikas TL (2006) Autologous fat grafting for midface rejuvenation. Facial Plast Surg Clin North Am 14:229–240

    PubMed  Article  Google Scholar 

  4. 4.

    Butterwick KJ, Nootheti PK, Hsu JW et al (2007) Autologous fat transfer: an in-depth look at varying concepts and techniques. Facial Plast Surg Clin North Am 15:99–111, viii

    PubMed  Article  Google Scholar 

  5. 5.

    Toledo LS, Mauad R (2006) Fat injection: a 20-year revision. Clin Plast Surg 33:47–53, vi

    PubMed  Article  Google Scholar 

  6. 6.

    Nquyen A, Pasyk KA, Bouvier TN et al (1990) Comparative study of survival of autologous adipose tissue taken and transplanted by different techniques. Plast Reconstr Surg 85:378–386

    Article  Google Scholar 

  7. 7.

    Billings E Jr, May JW Jr (1989) Historical review and present status of free fat graft autotransplantation in plastic and reconstructive surgery. Plast Reconstr Surg 83:368–381

    PubMed  Article  Google Scholar 

  8. 8.

    Coleman SR (1997) Facial recontouring with lipostructure. Clin Plast Surg 24:347–367

    PubMed  CAS  Google Scholar 

  9. 9.

    Zhu M, Zhou Z, Chen Y et al (2010) Supplementation of fat grafts with adipose-derived regenerative cells (ADRCs) improves long-term graft retention. Ann Plast Surg 64(2):222–228

    PubMed  Article  CAS  Google Scholar 

  10. 10.

    Ellenbogen R, Motykie G (2006) Adipose stem cells. Plast Surg Pract.

  11. 11.

    Yoshimura A, Aoi N, Kurita M et al (2010) Progenitor-enriched adipose tissue transplantation as rescue for breast implant complications. Breast J 16:169–175

    PubMed  Article  Google Scholar 

  12. 12.

    Yoshimura K, Sato K, Aoi N et al (2008) Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells. Aesthetic Plast Surg 32:48–55

    PubMed  Article  Google Scholar 

  13. 13.

    Strem BM, Hicok KC, Zhu M et al (2005) Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 54:132–141

    PubMed  Article  CAS  Google Scholar 

  14. 14.

    Aust L, Devlin B, Foster SJ, Halvorsen YD, Hicok K, du Laney T, Sen A, Willingmyre GD, Gimble JM (2004) Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy 6:7–14

    PubMed  Article  CAS  Google Scholar 

  15. 15.

    Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, Pell CL, Johnstone BH, Considine RV, March KL (2004) Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109:1292–1298

    PubMed  Article  Google Scholar 

  16. 16.

    Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279–4295

    PubMed  Article  CAS  Google Scholar 

Download references


The authors have no conflicts of interest to disclose.

Author information



Corresponding author

Correspondence to Tunc Tiryaki.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Tiryaki, T., Findikli, N. & Tiryaki, D. Staged Stem Cell-enriched Tissue (SET) Injections for Soft Tissue Augmentation in Hostile Recipient Areas: A Preliminary Report. Aesth Plast Surg 35, 965–971 (2011).

Download citation


  • Stem cells
  • Plastic surgery
  • SET
  • Hostile recipient area
  • Lipoinjection
  • Tissue engineering
  • Fat transplantation
  • Adipose-derived stem cells